These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 15727946

  • 1. Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty and Zucker rats.
    Oltman CL, Coppey LJ, Gellett JS, Davidson EP, Lund DD, Yorek MA.
    Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E113-22. PubMed ID: 15727946
    [Abstract] [Full Text] [Related]

  • 2. Onset of diabetes in Zucker diabetic fatty (ZDF) rats leads to improved recovery of function after ischemia in the isolated perfused heart.
    Wang P, Chatham JC.
    Am J Physiol Endocrinol Metab; 2004 May; 286(5):E725-36. PubMed ID: 14722022
    [Abstract] [Full Text] [Related]

  • 3. Changes in endoneurial blood flow, motor nerve conduction velocity and vascular relaxation of epineurial arterioles of the sciatic nerve in ZDF-obese diabetic rats.
    Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Yorek MA.
    Diabetes Metab Res Rev; 2002 May; 18(1):49-56. PubMed ID: 11921418
    [Abstract] [Full Text] [Related]

  • 4. Altered diaphragm muscle action potentials in Zucker diabetic fatty (ZDF) rats.
    van Lunteren E, Moyer M.
    Respir Physiol Neurobiol; 2006 Sep 28; 153(2):157-65. PubMed ID: 16311078
    [Abstract] [Full Text] [Related]

  • 5. The effects of zenarestat, an aldose reductase inhibitor, on peripheral neuropathy in Zucker diabetic fatty rats.
    Shimoshige Y, Ikuma K, Yamamoto T, Takakura S, Kawamura I, Seki J, Mutoh S, Goto T.
    Metabolism; 2000 Nov 28; 49(11):1395-9. PubMed ID: 11092500
    [Abstract] [Full Text] [Related]

  • 6. Altered triglyceride-rich lipoprotein production in Zucker diabetic fatty rats.
    Chirieac DV, Collins HL, Cianci J, Sparks JD, Sparks CE.
    Am J Physiol Endocrinol Metab; 2004 Jul 28; 287(1):E42-9. PubMed ID: 14970003
    [Abstract] [Full Text] [Related]

  • 7. Treatment of Zucker diabetic fatty rats with AVE7688 improves vascular and neural dysfunction.
    Oltman CL, Davidson EP, Coppey LJ, Kleinschmidt TL, Yorek MA.
    Diabetes Obes Metab; 2009 Mar 28; 11(3):223-33. PubMed ID: 18564175
    [Abstract] [Full Text] [Related]

  • 8. Vascular and neural dysfunction in Zucker diabetic fatty rats: a difficult condition to reverse.
    Oltman CL, Davidson EP, Coppey LJ, Kleinschmidt TL, Lund DD, Adebara ET, Yorek MA.
    Diabetes Obes Metab; 2008 Jan 28; 10(1):64-74. PubMed ID: 17970755
    [Abstract] [Full Text] [Related]

  • 9. Analysis of gene expression profiles in insulin-sensitive tissues from pre-diabetic and diabetic Zucker diabetic fatty rats.
    Suh YH, Kim Y, Bang JH, Choi KS, Lee JW, Kim WH, Oh TJ, An S, Jung MH.
    J Mol Endocrinol; 2005 Apr 28; 34(2):299-315. PubMed ID: 15821098
    [Abstract] [Full Text] [Related]

  • 10. Defect in glucokinase translocation in Zucker diabetic fatty rats.
    Fujimoto Y, Donahue EP, Shiota M.
    Am J Physiol Endocrinol Metab; 2004 Sep 28; 287(3):E414-23. PubMed ID: 15138155
    [Abstract] [Full Text] [Related]

  • 11. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds.
    Wasan KM, Risovic V, Yuen VG, McNeill JH.
    J Trace Elem Med Biol; 2006 Sep 28; 19(4):251-8. PubMed ID: 16443173
    [Abstract] [Full Text] [Related]

  • 12. Appropriateness of the Zucker Diabetic Fatty rat as a model for diabetic microvascular late complications.
    Hempe J, Elvert R, Schmidts HL, Kramer W, Herling AW.
    Lab Anim; 2012 Jan 28; 46(1):32-9. PubMed ID: 22087029
    [Abstract] [Full Text] [Related]

  • 13. Lipid-induced beta-cell dysfunction in vivo in models of progressive beta-cell failure.
    Goh TT, Mason TM, Gupta N, So A, Lam TK, Lam L, Lewis GF, Mari A, Giacca A.
    Am J Physiol Endocrinol Metab; 2007 Feb 28; 292(2):E549-60. PubMed ID: 17003242
    [Abstract] [Full Text] [Related]

  • 14. The development of overt diabetes in young Zucker Diabetic Fatty (ZDF) rats and the effects of chronic MCC-555 treatment.
    Pickavance L, Widdowson PS, King P, Ishii S, Tanaka H, Williams G.
    Br J Pharmacol; 1998 Oct 28; 125(4):767-70. PubMed ID: 9831913
    [Abstract] [Full Text] [Related]

  • 15. Pioglitazone reverses down-regulation of cardiac PPARgamma expression in Zucker diabetic fatty rats.
    Pelzer T, Jazbutyte V, Arias-Loza PA, Segerer S, Lichtenwald M, Law MP, Schäfers M, Ertl G, Neyses L.
    Biochem Biophys Res Commun; 2005 Apr 08; 329(2):726-32. PubMed ID: 15737646
    [Abstract] [Full Text] [Related]

  • 16. Swim training prevents hyperglycemia in ZDF rats: mechanisms involved in the partial maintenance of beta-cell function.
    Király MA, Bates HE, Kaniuk NA, Yue JT, Brumell JH, Matthews SG, Riddell MC, Vranic M.
    Am J Physiol Endocrinol Metab; 2008 Feb 08; 294(2):E271-83. PubMed ID: 18029442
    [Abstract] [Full Text] [Related]

  • 17. Time course of pain sensation in rat models of insulin resistance, type 2 diabetes, and exogenous hyperinsulinaemia.
    Sugimoto K, Rashid IB, Kojima K, Shoji M, Tanabe J, Tamasawa N, Suda T, Yasujima M.
    Diabetes Metab Res Rev; 2008 Feb 08; 24(8):642-50. PubMed ID: 18973207
    [Abstract] [Full Text] [Related]

  • 18. Characterization of diabetic neuropathy in the Zucker diabetic Sprague-Dawley rat: a new animal model for type 2 diabetes.
    Davidson EP, Coppey LJ, Holmes A, Lupachyk S, Dake BL, Oltman CL, Peterson RG, Yorek MA.
    J Diabetes Res; 2014 Feb 08; 2014():714273. PubMed ID: 25371906
    [Abstract] [Full Text] [Related]

  • 19. Skeletal muscle capillary responses to insulin are abnormal in late-stage diabetes and are restored by angiotensin-converting enzyme inhibition.
    Clerk LH, Vincent MA, Barrett EJ, Lankford MF, Lindner JR.
    Am J Physiol Endocrinol Metab; 2007 Dec 08; 293(6):E1804-9. PubMed ID: 17911341
    [Abstract] [Full Text] [Related]

  • 20. Attenuation of type 2 diabetes mellitus in the male Zucker diabetic fatty rat: the effects of stress and non-volitional exercise.
    Király MA, Bates HE, Yue JT, Goche-Montes D, Fediuc S, Park E, Matthews SG, Vranic M, Riddell MC.
    Metabolism; 2007 Jun 08; 56(6):732-44. PubMed ID: 17512304
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.